Content about CAMBRIDGE

March 22, 2013
Genzyme drug shows improvement in MS patients

Disease relapse rates and worsening of disability were low among patients taking a drug made by Genzyme for multiple sclerosis, the company said.

January 28, 2013
FDA accepts application for Genzyme MS drug

The Food and Drug Administration has accepted a regulatory approval application from Genzyme for an experimental treatment for multiple sclerosis, the company said Monday.

October 19, 2012
Improved adherence, med management can reduce hospital re-admissions, healthcare group says

Improving medication adherence may be the key to reducing hospital re-admission rates, according to a new issue brief by a health policy research organization.

October 16, 2012
Target awareness strong even before Canadian entry

Target should be feeling confident about its upcoming entry into Canada, as a recent survey from Kantar Retail and TNS Canada revealed that 75% of Canadians are aware of the retailer.

October 9, 2012
Sanofi, Massachusetts General Hospital enter collaboration

A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

October 8, 2012
Kantar Retail survey: Dollar General offers least expensive basket price

Dollar General is the overall basket price leader, delivering a substantial savings to value shoppers, according to Kantar Retail's second annual opening price point survey.

October 2, 2012
Genzyme drug for Gaucher disease reduces enlarged spleen size in trial

An experimental drug for treating a rare genetic disease appears effective, according to a late-stage clinical trial.

September 13, 2012
FDA approves new MS drug

The Food and Drug Administration has approved a new drug for multiple sclerosis.

September 10, 2012
AstraZeneca, Broad Institute partner on antibiotic, antiviral drugs

A drug maker and medical research institute will work together to identify new treatments for bacterial and viral infections.

September 6, 2012
Study shows rapid growth in cost of physician-dispensed prescriptions versus pharmacies

While regulations meant to control the prices of drugs dispensed through physician offices for injured workers can keep costs down without limiting access, employers in many states may end up paying more than twice what they would have if the workers had gone to a pharmacy instead, according to a new study.

June 13, 2012
Upsher-Smith to acquire biotechnology firm Proximagen Group

Upsher-Smith Labs on Wednesday announced that it has agreed to acquire Proximagen Group, a European biotechnology company focused on the development and commercialization of novel therapeutics for diseases of the central nervous system and inflammation.

June 1, 2012
Patients with MS show reduction in symptoms during drug trial

An experimental drug for multiple sclerosis produced a noticeable reduction in symptoms of the disease in a late-stage clinical trial, the drug's developer said Friday.

May 9, 2012
AeroShot launches chocolate product

An aerodynamic chocolate product, invented by Harvard professor David Edwards, has made its U.S. debut.

April 20, 2012
Genzyme to present MS drug trials

Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.

March 6, 2012
Takeda unit starts trial of lymphoma drug

Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.

January 24, 2012
FDA approves new administration method for Takeda cancer drug

The Food and Drug Administration has approved a new means of administering a cancer drug made by Takeda, the drug maker said.

December 21, 2011
Genzyme reports lackluster results in MS drug trial

An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.

December 19, 2011
Nielsen Holdings elevates two executives

Nielsen Holdings on Monday announced that Rick Kash has been appointed vice chair and will join CEO David Calhoun and vice chair Susan Whiting in the office of the CEO. Nielsen also named Mitchell Habib COO.

December 16, 2011
Living Proof names CEO

Beauty company Living Proof has announced the appointment of Jill Beraud as CEO, effective Jan. 9.

December 15, 2011
Report: Making medical technology consumer-friendly will drive wellness market

Cambridge Consultants on Thursday released a report outlining how the health-and-wellness market may take shape as more consumer-friendly medical devices featuring the latest in technology reach the market.

November 23, 2011
PatientsLikeMe to introduce daily blood-glucose monitoring feature

An online data sharing platform announced it will debut a daily blood-glucose monitoring feature for its more than 2,000 diabetes patients.

November 14, 2011
Genzyme announces phase-3 results of Lemtrada in patients with relapsing MS

A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.

November 10, 2011
Genzyme names leaders of MS, rare diseases units

Genzyme has named leaders of two units that are part of the core focus of the drug maker's business.

November 2, 2011
FDA approves update to Takeda cancer drug label

The Food and Drug Administration has approved changes to the labeling of a cancer drug made by Takeda Pharmaceuticals, the drug maker said.

October 25, 2011
Sanofi appoints David Meeker as CEO of Genzyme

Sanofi has appointed David Meeker as CEO of Genzyme, the French drug maker said.

© 2013 Drug Store News. All Rights Reserved.